{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T15:40:07Z","timestamp":1750606807229,"version":"3.41.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,22]]},"DOI":"10.7759\/cureus.86538","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T15:11:48Z","timestamp":1750605108000},"source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia"],"prefix":"10.7759","author":[{"given":"Nicolas","family":"Zapata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Georgiadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Cantrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan G","family":"Rilinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackaleigh A","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2022.08.002","article-title":"Dysautonomia: diagnosis and management","volume":"41","author":"Hovaguimian A","year":"2023","unstructured":"Hovaguimian A. Dysautonomia: diagnosis and management. Neurol Clin. 2023, 41:193-213. 10.1016\/j.ncl.2022.08.002","journal-title":"Neurol Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2024.02.006","article-title":"Autonomic dysfunction from diagnosis to treatment","volume":"51","author":"Peltier AC","year":"2024","unstructured":"Peltier AC. Autonomic dysfunction from diagnosis to treatment. Prim Care. 2024, 51:359-73. 10.1016\/j.pop.2024.02.006","journal-title":"Prim Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1","volume":"235","author":"Vernino S","year":"2021","unstructured":"Vernino S, Bourne KM, Stiles LE, et al.. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021, 235:102828. 10.1016\/j.autneu.2021.102828","journal-title":"Auton Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0076-8","article-title":"Autonomic dysfunction in fibromyalgia syndrome: postural orthostatic tachycardia","volume":"10","author":"Staud R","year":"2008","unstructured":"Staud R. Autonomic dysfunction in fibromyalgia syndrome: postural orthostatic tachycardia. Curr Rheumatol Rep. 2008, 10:463-6. 10.1007\/s11926-008-0076-8","journal-title":"Curr Rheumatol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2086","article-title":"The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders","volume":"38","author":"Patten DK","year":"2018","unstructured":"Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders. Pharmacotherapy. 2018, 38:382-9. 10.1002\/phar.2086","journal-title":"Pharmacotherapy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger J","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014, 33:451-9. 10.1007\/s10067-014-2517-2","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S451183","article-title":"Effective doses of low-dose naltrexone for chronic pain - an observational study","volume":"17","author":"Marcus NJ","year":"2024","unstructured":"Marcus NJ, Robbins L, Araki A, Gracely EJ, Theoharides TC. Effective doses of low-dose naltrexone for chronic pain - an observational study. J Pain Res. 2024, 17:1273-84. 10.2147\/JPR.S451183","journal-title":"J Pain Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040082","article-title":"Low-dose naltrexone (LDN)-review of therapeutic utilization","volume":"6","author":"Toljan K","year":"2018","unstructured":"Toljan K, Vrooman B. Low-dose naltrexone (LDN)-review of therapeutic utilization. Med Sci (Basel). 2018, 6:82. 10.3390\/medsci6040082","journal-title":"Med Sci (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1049909119838974","article-title":"Pharmacology update: low-dose naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes","volume":"36","author":"Trofimovitch D","year":"2019","unstructured":"Trofimovitch D, Baumrucker SJ. Pharmacology update: low-dose naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes. Am J Hosp Palliat Care. 2019, 36:907-12. 10.1177\/1049909119838974","journal-title":"Am J Hosp Palliat Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnad074","article-title":"Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review","volume":"24","author":"Rupp A","year":"2023","unstructured":"Rupp A, Young E, Chadwick AL. Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review. Pain Med. 2023, 24:1270-81. 10.1093\/pm\/pnad074","journal-title":"Pain Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4110","article-title":"A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study","volume":"26","author":"Raknes G","year":"2017","unstructured":"Raknes G, Sm\u00e5brekke L. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study. Pharmacoepidemiol Drug Saf. 2017, 26:136-42. 10.1002\/pds.4110","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score","volume":"87","author":"Sletten DM","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012, 87:1196-201. 10.1016\/j.mayocp.2012.10.013","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43426","article-title":"Low-dose naltrexone use in postural orthostatic tachycardia syndrome: a case series","volume":"15","author":"Stallkamp Tidd SJ","year":"2023","unstructured":"Stallkamp Tidd SJ, Cantrell C, Greene BD, Wilson R. Low-dose naltrexone use in postural orthostatic tachycardia syndrome: a case series. Cureus. 2023, 15:e43426. 10.7759\/cureus.43426","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1297964","article-title":"Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon","volume":"15","author":"Cantrell C","year":"2024","unstructured":"Cantrell C, Reid C, Walker CS, Stallkamp Tidd SJ, Zhang R, Wilson R. Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon. Front Neurol. 2024, 15:1297964. 10.3389\/fneur.2024.1297964","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31021","article-title":"Skin biopsy and quantitative sudomotor axon reflex testing in patients with postural orthostatic tachycardia syndrome","volume":"14","author":"Zhang R","year":"2022","unstructured":"Zhang R, Mayuga K, Shields R, Cantrell C, Wilson R. Skin biopsy and quantitative sudomotor axon reflex testing in patients with postural orthostatic tachycardia syndrome. Cureus. 2022, 14:e31021. 10.7759\/cureus.31021","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jabr.12135","article-title":"Phenotypic features of central sensitization","volume":"23","author":"Williams DA","year":"2018","unstructured":"Williams DA. Phenotypic features of central sensitization. J Appl Biobehav Res. 2018, 23:e12135. 10.1111\/jabr.12135","journal-title":"J Appl Biobehav Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1476918","article-title":"Orthostatic intolerance with tachycardia (postural tachycardia syndrome) and without (hypocapnic cerebral hypoperfusion) represent a spectrum of the same disorder","volume":"15","author":"Novak P","year":"2024","unstructured":"Novak P, Systrom DM, Witte A, Marciano SP. Orthostatic intolerance with tachycardia (postural tachycardia syndrome) and without (hypocapnic cerebral hypoperfusion) represent a spectrum of the same disorder. Front Neurol. 2024, 15:1476918. 10.3389\/fneur.2024.1476918","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30167","article-title":"A survey-based study examining differences in perception of postural orthostatic tachycardia syndrome between patients and primary care physicians","volume":"14","author":"Cooperrider J","year":"2022","unstructured":"Cooperrider J, Kriegler J, Yunus S, Wilson R. A survey-based study examining differences in perception of postural orthostatic tachycardia syndrome between patients and primary care physicians. Cureus. 2022, 14:e30167. 10.7759\/cureus.30167","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375462-low-dose-naltrexone-for-managing-pain-and-autonomic-symptoms-in-patients-with-dysautonomia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T15:11:49Z","timestamp":1750605109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375462-low-dose-naltrexone-for-managing-pain-and-autonomic-symptoms-in-patients-with-dysautonomia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.86538","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,22]]}}}